YOU ARE HERE:

COVID-19 NEUROSCIENCE STUDY

I have been participating in the COPING study filling in questionnaires about my mood etc. since nearly the beginning of the pandemic. This is run by King’s College London and now they have secured nearly £3 million to launch the COVID-19 Clinical Neuroscience Study.

“Covid-19 has been associated with neurological and/or psychiatric complications in 1/3 of hospitalised patients. COVID-CNS intends to investigate underlying mechanisms to find new treatments by sampling adults 16 and over, who have or have not experienced these types of complications after being diagnosed with COVID-19 including encephalopathy, encephalitis, catatonia, psychosis, stroke, and Parkinsonism.

These are often otherwise unexplained (i.e. excluding risk factors/hypoxia/iatrogenic causes) and often occur in younger patients. Survivors frequently report cognitive impairment, fatigue and depression. The limited regenerative capacity of the brain means these complications may cause lifelong disability.”

See https://www.kcl.ac.uk/news/new-national-study-into-neurological-impact-of-covid-19

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email
news

Become a member and be kept up to date with the news

(approximately monthly email)